Prostate-Cancer Test Not Worth Risk, Panel Says - BusinessWeek

CBS News

Prostate-Cancer Test Not Worth Risk, Panel Says BusinessWeek By Alex Nussbaum on May 21, 2012 The PSA prostate-cancer test used by half of US men older than 40 carries more risks than benefits and shouldn't be used to diagnose the disease, a US panel said, reaffirming its earlier advice. Prostate-Cancer Test Not Worth Risk, Advisory Panel SaysBloomberg Prostate cancer and the PSA test: It's hard to understand riskLos Angeles Times Health experts: Routine PSA tests for prostate cancer not good for healthCBS News NPR (blog) all 297 news articles »

Studies Reveal New Prostate Cancer Mutation Profiles, Subtypes - GenomeWeb

Zee News

Studies Reveal New Prostate Cancer Mutation Profiles, Subtypes GenomeWeb "Our integrated, exome-based profiling of the mutational landscape of [castration-resistant prostate cancer] is notable for representing a large cohort of heavily pre-treated patients with lethal metastatic disease, which are not commonly studied," ... New type of prostate cancer discoveredZee News Scientists find new type of prostate cancer - discovery may lead to tailored ...New York Daily News Scientists discover new type of prostate cancerFox News Cornell Chronicle -The Inquisitr all 20 news articles »